(Q33731230)

English

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease (English)

1 reference

Europe PubMed Central

29 July 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Andrew John Lees

2

object named as

A J Lees

1 reference

Europe PubMed Central

29 July 2017

Marcelo Merello

1

object named as

M Merello

1 reference

Europe PubMed Central

29 July 2017

author name string

R Webster

3

1 reference

Europe PubMed Central

29 July 2017

M Bovingdon

4

1 reference

Europe PubMed Central

29 July 2017

A Gordin

5

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 February 1994

1 reference

Europe PubMed Central

29 July 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

29 July 2017

57

1 reference

Europe PubMed Central

29 July 2017

2

1 reference

Europe PubMed Central

29 July 2017

186-189

1 reference

Europe PubMed Central

29 July 2017

Effects of 3-OM-dopa on monoamine metabolism in rat brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Potentiation of the l-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Response to brief levodopa infusions in parkinsonian patients with and without motor fluctuations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Clinical significance of the relationship between O-methyldopa levels and levodopa intake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Computerized rotometer apparatus for recording circling behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Expression of heat shock proteins in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

18F‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Deprenyl in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1072447

14 July 2018

Purification and Properties of a Catechol-O-Methyltransferase of Human Liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parkinsonism treated with 3-O-methyldopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Catechol-O-methyltransferase and Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of Levodopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3-O-methyldopa and motor fluctuations in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3-O-methyldopa and the response to levodopa in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Catechol-O-methyltransferase activity in human and rat small intestine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-dopa in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of circulating 3-O-methyldopa by inhibition of catechol-O-methyltransferase with OR-611 and OR-462 in cynomolgus monkeys: implications for the treatment of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8126502

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.57.2.186

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33731230&oldid=1797718331"